Drug Shortage Report for PMS-RANITIDINE 300 MG
Report ID | 98843 |
Drug Identification Number | 02242454 |
Brand name | PMS-RANITIDINE 300 MG |
Common or Proper name | RANITIDINE 300 MG |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 30 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-10-23 |
Estimated end date | |
Actual end date | 2021-12-07 |
Shortage status | Resolved |
Updated date | 2021-12-08 |
Company comments | **** DISCONTINUED **** |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2021-12-08 | French | Compare |
v3 | 2021-12-08 | English | Compare |
v2 | 2019-11-15 | French | Compare |
v1 | 2019-11-15 | English | Compare |
Showing 1 to 4 of 4